NCT06550479 Comparison of Three Types of Distal Arteriovenous Fistulas: SBAVF, RCAVF, and RCAVF With Venous Branch Patch.
| NCT ID | NCT06550479 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wroclaw Medical University |
| Condition | Dialysis; Complications |
| Study Type | INTERVENTIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 180 participants in total. It began in 2024-01-01 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to determine which type of distal arteriovenous fistula (SBAVF, RCAVF, and RCAVF with venous branch patch) is most clinically favorable. The recommendations and scientific evidence do not suggest which option should be chosen initially. The investigators expect that results will show which type of the anastomosis should be preferred.
Eligibility Criteria
Inclusion Criteria: * Aged \>18 years * Chronic kidney disease with estimated glomerular filtration rate (eGFR) \<20 mL/min/1.73 m2 Exclusion Criteria: * Heart failure of New York Heart Association functional class III or IV, * Episode of cardio- or cerebrovascular event or receiving intervention therapy within 3 months prior to screening. * The patient had the primary anastomosis in the past on ipsilateral extremity
Frequently Asked Questions
Who can join the NCT06550479 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dialysis; Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06550479 currently recruiting?
Yes, NCT06550479 is actively recruiting participants. Visit ClinicalTrials.gov or contact Wroclaw Medical University to inquire about joining.
Where is the NCT06550479 trial being conducted?
This trial is being conducted at Wroclaw, Poland.
Who is sponsoring the NCT06550479 clinical trial?
NCT06550479 is sponsored by Wroclaw Medical University. The trial plans to enroll 180 participants.